Search results
Produce a new standalone guideline on uncontrolled asthma that includes guidance on pharmacological management (specifically biologics), assessment, phenotyping, high-risk patients, biomarkers and monitoring (replacing the existing sections 7 and 10).
The guideline considers diagnosis of asthma and management in all patients with a diagnosis of asthma, although there is less evidence available for people at either age extreme.
BTS/SIGN British Guideline on the Management of Asthma. BTS/SIGN/NICE joint Guideline for the Diagnosis, Monitoring and Management of Chronic Asthma. The draft guideline, evidence reviews and information on the consultation on the guideline is here.
This Quick Reference Guide provides a summary of the main recommendations in SIGN 158 British guideline on the management of asthma. Recommendations are graded A B C D to indicate the strength of the supporting evidence.
SIGN guidelines are produced using a standard methodology that has been equality impact assessed to ensure that these equality aims are addressed in every guideline. This methodology is set out in the current version of SIGN 50, our guideline manual, which can be found at www.sign.ac.uk/guidelines/fulltext/50/index.html.
This Quick Reference Guide provides a summary of the main recommendations in SIGN 153 British guideline on the management of asthma. Recommendations are graded A B C D to indicate the strength of the supporting evidence.
The diagnosis of asthma is based on the recognition of a characteristic pattern of symptoms and signs and the absence of an alternative explanation for them. The key is to take a careful clinical history.
